State University Of New York
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1948-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.suny.edu/
Clinical Trials
2
Active:0
Completed:2
Trial Phases
2 Phases
Phase 2:1
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (50.0%)Phase 3
1 (50.0%)Phase III Randomized Study of Collagenase in Patients With Residual Stage Dupuytren's Disease
Phase 3
Completed
- Conditions
- Dupuytren's Contracture
- First Posted Date
- 2001-04-11
- Last Posted Date
- 2015-03-25
- Lead Sponsor
- State University of New York
- Target Recruit Count
- 72
- Registration Number
- NCT00014742
Phase II Randomized Study of Collagenase in Patients With Residual Type Dupuytren's Disease
Phase 2
Completed
- Conditions
- Dupuytren's Contracture
- First Posted Date
- 1999-10-19
- Last Posted Date
- 2015-03-25
- Lead Sponsor
- State University of New York
- Target Recruit Count
- 36
- Registration Number
- NCT00004409
- Locations
- 🇺🇸
Stanford University Hospital, Palo Alto, California, United States
🇺🇸State University of New York Health Sciences Center - Stony Brook, Stony Brook, New York, United States
News
No news found